BA
CL icon

Bridgewater Associates’s Colgate-Palmolive CL Stock Holding History

Bridgewater Associates’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.2M Buy
84,507
+21,404
+34% +$1.91M 0.03% 331
2025
Q4 		$4.99M Sell
63,103
-57,577
-48% -$4.51M 0.02% 529
2025
Q3 		$9.65M Buy
120,680
+74,730
+163% +$6.37M 0.04% 337
2025
Q2 		$4.18M Sell
45,950
-14,712
-24% -$1.34M 0.02% 350
2025
Q1 		$5.68M Sell
60,662
-89,572
-60% -$8.02M 0.03% 337
2024
Q4 		$13.7M Sell
150,234
-456,387
-75% -$43.6M 0.06% 212
2024
Q3 		$63M Sell
606,621
-672,617
-53% -$68.6M 0.36% 56
2024
Q2 		$124M Sell
1,279,238
-13,561
-1% -$1.25M 0.65% 27
2024
Q1 		$116M Sell
1,292,799
-254,087
-16% -$21.5M 0.59% 39
2023
Q4 		$123M Sell
1,546,886
-152,761
-9% -$11.5M 0.69% 29
2023
Q3 		$121M Buy
1,699,647
+60,019
+4% +$4.49M 0.73% 25
2023
Q2 		$126M Sell
1,639,628
-64,120
-4% -$4.96M 0.78% 24
2023
Q1 		$128M Sell
1,703,748
-188,986
-10% -$14.1M 0.78% 23
2022
Q4 		$149M Sell
1,892,734
-537,268
-22% -$40.3M 0.81% 19
2022
Q3 		$171M Buy
2,430,002
+139,805
+6% +$11M 0.86% 20
2022
Q2 		$184M Sell
2,290,197
-337,239
-13% -$26.4M 0.78% 19
2022
Q1 		$199M Buy
2,627,436
+728,497
+38% +$57.7M 0.8% 19
2021
Q4 		$162M Buy
1,898,939
+231,899
+14% +$18.1M 0.94% 20
2021
Q3 		$126M Sell
1,667,040
-6,986
-0.4% -$555K 0.69% 26
2021
Q2 		$136M Buy
1,674,026
+559,857
+50% +$45.8M 0.87% 24
2021
Q1 		$87.8M Buy
1,114,169
+212,672
+24% +$16.7M 0.77% 26
2020
Q4 		$77.1M Buy
901,497
+474,542
+111% +$39.2M 0.67% 33
2020
Q3 		$32.9M Buy
+426,955
New +$32.6M 0.4% 37
2020
Q2 		– Sell
-31,361
Closed -$2.08M – 411
2020
Q1 		$2.08M Buy
+31,361
New +$2.21M 0.04% 124
2019
Q4 		– Sell
-20,802
Closed -$1.53M – 491
2019
Q3 		$1.53M Buy
+20,802
New +$1.51M 0.01% 210
2019
Q2 		– Sell
-3,145
Closed -$216K – 325
2019
Q1 		$216K Sell
3,145
-576,766
-99% -$37.3M ﹤0.01% 300
2018
Q4 		$34.5M Buy
579,911
+488,966
+538% +$30.6M 0.32% 40
2018
Q3 		$6.09M Buy
+90,945
New +$6.06M 0.06% 110
2017
Q1 		– Sell
-7,768
Closed -$508K – 255
2016
Q4 		$508K Buy
+7,768
New +$533K ﹤0.01% 245
2016
Q3 		– Sell
-11,300
Closed -$827K – 321
2016
Q2 		$827K Buy
+11,300
New +$805K 0.01% 251
2016
Q1 		– Sell
-122,706
Closed -$8.18M – 262
2015
Q4 		$8.18M Buy
+122,706
New +$8.16M 0.11% 84
2015
Q1 		– Sell
-53,471
Closed -$3.7M – 344
2014
Q4 		$3.7M Buy
53,471
+31,665
+145% +$2.14M 0.03% 142
2014
Q3 		$1.42M Buy
+21,806
New +$1.44M 0.01% 194

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bridgewater Associates's CL Position: Q1 2026 in Review

Bridgewater Associates increased its Colgate-Palmolive (CL) stake by 34% in Q1 2026, buying an estimated $1.91M and bringing the position to 84,507 shares worth $7.2M. The position accounts for 0.03% of the portfolio, ranked #331.

Bridgewater Associates first reported a position in CL in Q3 2014 and has held it in 33 quarters since. The position peaked at $199M in Q1 2022. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Bridgewater Associates held 84,507 shares of Colgate-Palmolive worth $7.2M as of Q1 2026.
  • Bridgewater Associates bought 21,404 Colgate-Palmolive shares in Q1 2026, an estimated $1.91M.
  • Colgate-Palmolive made up 0.03% of Bridgewater Associates's portfolio in Q1 2026, its #331 holding.
  • Bridgewater Associates first reported a position in Colgate-Palmolive in Q3 2014 and has held it in 33 quarters since.
  • Bridgewater Associates's Colgate-Palmolive position peaked at $199M in Q1 2022.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.